Skip to main content
Equibles

UBS Group AG

Position in ZLAB — Zai Lab Ltd

CIK 1610520 ZURICH, V8
Back to ZLAB Full portfolio

Position in ZLAB

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$1,319,626
-$8,164,204 QoQ
Shares Held
69,454
-86.2% QoQ
Ownership
0.062%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#39
of 92 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 94% Shared 0% None 6%

Common Shares in ZLAB Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,789,675,801 across 560 Biotechnology names. ZLAB ranks #248 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RVMD
Revolution Medicines, Inc.
 5,450,825 $1,020,369,609
2 ROIV
Roivant Sciences Ltd.
 17,466,641 $618,144,423
3 PTGX
Protagonist Therapeutics, Inc
 3,399,221 $416,676,508
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 712,259 $353,800,411
5 MRNA
Moderna, Inc.
 4,463,211 $312,558,664
6 INSM
INSMED Inc
 2,584,446 $275,553,630
7 ABVX
Abivax S.A.
 1,844,918 $245,853,771
8 MDGL
Madrigal Pharmaceuticals, Inc.
 401,708 $215,697,109

All Filings in ZLAB

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,319,626 69,454
2026-03-31 $9,483,830 504,191
2025-12-31 $31,438,925 1,782,252
2025-09-30 $10,389,114 306,554
2025-06-30 $8,450,500 241,650
2025-03-31 $14,207,248 393,117
2024-12-31 $23,015,824 878,802
2024-09-30 $440,748 18,258
2024-06-30 $753,594 43,485
2024-03-31 $1,326,183 82,783
2023-12-31 $681,965 24,953
2023-09-30 $7,025,128 288,981
2023-06-30 $1,943,152 70,074
2023-03-31 $6,569,415 197,517
2022-12-31 $6,728,242 219,161
2022-09-30 $5,162,694 150,956
2022-06-30 $5,284,607 152,382
2022-03-31 $6,613,580 150,377
2021-12-31 $14,301,327 227,547
2021-09-30 $26,737,441 253,700
2021-06-30 $38,204,176 215,855
2021-03-31 $25,737,578 192,892
2020-12-31 $25,698,494 189,881
2020-09-30 $26,297,023 316,184
2020-06-30 $18,909,117 230,234
2020-03-31 $12,425,109 241,358